The next head of the World Trade Organization needs recent experience in managing a coronavirus epidemic, argues South Korean candidate Yu Myung-hee. She One of the eight claimants Succeeding Brazilian Roberto Azewado as Director General of the WTO.
South African President Cyril Ramaphosa is facing increasing pressure to accelerate power and telecom sector reform in the continent’s most industrialized industrial economy since the epidemic. Erased more than a decade Delicate growth. Gross domestic product fell in the second quarter to about a fifth year in a row.
This weekend calls 600bn reinsurance industry executives access video calls, so they can be forgiven for thinking confidently about Monaco. They must have gathered in the glitz of the kingdom on the French coast, but the epidemic has put an annual fate Rendez-Vosus d September Is in danger.
In the scoreboard, U.S. The return of the National Football League begins its crucial reconsideration from the start of the clock B 5bn media rights deals, Wondering about the true value of the English Premier League club after Leeds United’s promotion and explaining the reasoning behind Dewart Beckham’s bet on the Asparts team.
UK fashion retailer New Look is gearing up for another confrontation with its landlords next week as it prepares to demand bigger cuts in rent with a warning. It could go bust Without them. The company has about 500 stores and employs more than 12,000 people.
Gilead Science – in the spotlight of Remdesivir, a drug that received emergency approval for the treatment of Covid-19 – is close to buying immunomidics for bn 20bn, as the pharmaceutical group tries Outbid competitors Cancer competes to snatch the drug developer. Gilead’s offer for immunomidics is almost double the price.
Masayoshi Dikara, founder of Japan Group, has resumed talks on the merger after throwing weight behind the deal, according to shareholders, including Southeast Asia’s largest start-up Gojek and Grub Softbank. Discussions resume as harmful rivals Hemorrhage Money due to Covid-19 sanctions.
Oxford University and AstraZeneca are set to resume international clinical trials of their proposed coronavirus. Vaccine candidate. There is speculation that the much-watched study could be significantly delayed and turned out to be ineligible. The trial was suspended last Sunday when a participant fell ill in the UK.
